Equine herpesviruses type 1 (EHV-1) and 4 (EHV-4)-Masters of co-evolution and a constant threat to equids and beyond

Veterinary Microbiology

Volumn 167, Issue 1-2, 2013, Pages 123-134

  Ma, Guanggang ^a   Azab, Walid ^a,b   Osterrieder, Nikolaus ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b Zagazig University   (Egypt)

Author keywords

EHV 1; EHV 4; Entry Receptor; Host range; Immune evasion; Vaccine

Indexed keywords

CHEMOKINE; DUVAXYN 1 4; FLUVAC INNOVATOR 6 COMBINATION VACCINE; HERPES VACCINE; INACTIVATED VIRUS VACCINE; INTERLEUKIN 8; KERATINOCYTE DERIVED CHEMOKINE; LIVE VACCINE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; NEUTRALIZING ANTIBODY; PNEUMABORT K; PREVACCINOL; PRODIGY; RECOMBINANT VACCINE; RHINOMUNE; SUBUNIT VACCINE; UNCLASSIFIED DRUG; VIRUS ANTIGEN;

ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ANTIGEN PRESENTATION; ARTICLE; BRAIN DISEASE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CYTOTOXIC T LYMPHOCYTE; DRUG EFFICACY; DRUG SAFETY; EQUINE HERPES VIRUS; EQUINE HERPESVIRUS MYELOENCEPHALOPATHY; HERPES VIRUS INFECTION; HORSE DISEASE; HOST RANGE; HUMORAL IMMUNITY; IMMUNOMODULATION; INFECTION RISK; INNATE IMMUNITY; MOLECULAR EVOLUTION; NEWBORN DEATH; NONHUMAN; PROTECTION; RESPIRATORY TRACT INFECTION; SEROEPIDEMIOLOGY; SINGLE NUCLEOTIDE POLYMORPHISM; SPINAL CORD DISEASE; VACCINATION; VETERINARY ABORTION; VIRAL TROPISM; VIRUS CELL INTERACTION; VIRUS DIAGNOSIS; VIRUS ENTRY; VIRUS MUTANT; VIRUS REPLICATION; VIRUS STRAIN; VIRUS VIRULENCE;

EQUID HERPESVIRUS 1; EQUID HERPESVIRUS 4; EQUIDAE;

EHV-1; EHV-4; ENTRY RECEPTOR; HOST RANGE; IMMUNE EVASION; VACCINE;

ANIMALS; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 1, EQUID; HERPESVIRUS 4, EQUID; HORSE DISEASES; HORSES; VIRUS INTERNALIZATION;

EID: 84889080820     PISSN: 03781135     EISSN: 18732542     Source Type: Journal    
DOI: 10.1016/j.vetmic.2013.06.018     Document Type: Article

References (117)

1. Allen G.P. Risk factors for development of neurologic disease after experimental exposure to equine herpesvirus-1 in horses. Am. J. Vet. Res. 2008, 69:1595-1600.
2. Allen G.P., Bolin D.C., Bryant U., Carter C.N., Giles R.C., Harrison L.R., Hong C.B., Jackson C.B., Poonacha K., Wharton R., Williams N.M. Prevalence of latent, neuropathogenic equine herpesvirus-1 in the Thoroughbred broodmare population of central Kentucky. Equine Vet. J. 2008, 40:105-110.
3. Allen G.P., Breathnach C.C. Quantification by real-time PCR of the magnitude and duration of leucocyte-associated viraemia in horses infected with neuropathogenic vs. non-neuropathogenic strains of EHV-1. Equine Vet. J. 2006, 38:252-257.
4. Allen G.P., Bryans J.T. Molecular epizootiology, pathogenesis, and prophylaxis of equine herpesvirus-1 infections. Prog. Vet. Microbiol. Immunol. 1986, 2:78-144.
5. Ataseven V.S., Dagalp S.B., Guzel M., Basaran Z., Tan M.T., Geraghty B. Prevalence of equine herpesvirus-1 and equine herpesvirus-4 infections in equidae species in Turkey as determined by ELISA and multiplex nested PCR. Res. Vet. Sci. 2009, 86:339-344.
6. Azab W., Kato K., Arii J., Tsujimura K., Yamane D., Tohya Y., Matsumura T., Akashi H. Cloning of the genome of equine herpesvirus 4 strain TH20p as an infectious bacterial artificial chromosome. Arch. Virol. 2009, 154:833-842.
7. Azab W., Lehmann M.J., Osterrieder N. Glycoprotein H and alpha4beta1 integrins determine the entry pathway of alphaherpesviruses. J. Virol. 2013, 87:5937-5948.
8. Azab W., Osterrieder N. Glycoproteins D of equine herpesvirus type 1 (EHV-1) and EHV-4 determine cellular tropism independently of integrins. J. Virol. 2012, 86:2031-2044.
9. Azab W., Tsujimura K., Maeda K., Kobayashi K., Mohamed Y.M., Kato K., Matsumura T., Akashi H. Glycoprotein C of equine herpesvirus 4 plays a role in viral binding to cell surface heparan sulfate. Virus Res. 2010, 151:1-9.
10. Azab W., Zajic L., Osterrieder N. The role of glycoprotein H of equine herpesviruses 1 and 4 (EHV-1 and EHV-4) in cellular host range and integrin binding. Vet. Res. 2012, 43:61.
11. Blunden A.S., Smith K.C., Binns M.M., Zhang L., Gower S.M., Mumford J.A. Replication of equid herpesvirus 4 in endothelial cells and synovia of a field case of viral pneumonia and synovitis in a foal. J. Comp. Pathol. 1995, 112:133-140.
12. Borchers K., Wolfinger U., Lawrenz B., Schellenbach A., Ludwig H. Equine herpesvirus 4 DNA in trigeminal ganglia of naturally infected horses detected by direct in situ PCR. J. Gen. Virol. 1997, 78(Pt 5):1109-1114.
13. Borchers K., Wolfinger U., Ludwig H. Latency-associated transcripts of equine herpesvirus type 4 in trigeminal ganglia of naturally infected horses. J. Gen. Virol. 1999, 80(Pt 8):2165-2171.
14. Bresgen C., Lammer M., Wagner B., Osterrieder N., Damiani A.M. Serological responses and clinical outcome after vaccination of mares and foals with equine herpesvirus type 1 and 4 (EHV-1 and EHV-4) vaccines. Vet. Microbiol. 2012, 160:9-16.
15. Bryant N.A., Davis-Poynter N., Vanderplasschen A., Alcami A. Glycoprotein G isoforms from some alphaherpesviruses function as broad spectrum chemokine binding proteins. EMBO J. 2003, 22:833-846.
16. Carvalho R., Oliveira A.M., Souza A.M., Passos L.M., Martins A.S. Prevalence of equine herpesvirus type 1 latency detected by polymerase chain reaction. Arch. Virol. 2000, 145:1773-1787.
17. Charan S., Palmer K., Chester P., Mire-Sluis A.R., Meager A., Edington N. Transforming growth factor-fl induced by live or ultraviolet-inactivated equid herpes virus type-1 mediates immunosuppression in the horse. Immunology 1997, 90:586-591.
18. Chesters P.M., Allsop R., Purewal A., Edington N. Detection of latency-associated transcripts of equid herpesvirus 1 in equine leukocytes but not in trigeminal ganglia. J. Virol. 1997, 71:3437-3443.
19. Chowdhury S.I., Ludwig H., Buhk H.J. Molecular biological characterization of equine herpesvirus type 1 (EHV-1) isolates from ruminant hosts. Virus Res. 1988, 11:127-139.
20. Crabb B.S., Nagesha H.S., Studdert M.J. Identification of equine herpesvirus 4 glycoprotein G: a type-specific, secreted glycoprotein. Virology 1992, 190:143-154.
21. Crabb B.S., Studdert M.J. Epitopes of glycoprotein G of equine herpesviruses 4 and 1 located near the C termini elicit type-specific antibody responses in the natural host. J. Virol. 1993, 67:6332-6338.
22. David-Watine B., Israel A., Kourilsky P. The regulation and expression of MHC class I genes. Immunol. Today 1990, 11:286-292.
23. Davison A.J., Eberle R., Ehlers B., Hayward G.S., McGeoch D.J., Minson A.C., Pellett P.E., Roizman B., Studdert M.J., Thiry E. The order herpesvirales. Arch. Virol. 2009, 154:171-177.
24. Dubin G., Socolof E., Frank I., Friedman H.M. Herpes simplex virus type 1 Fc receptor protects infected cells from antibody-dependent cellular cytotoxicity. J. Virol. 1991, 65:7046-7050.
25. Dustin M.L., Rothlein R., Bhan A.K., Dinarello C.A., Springer T.A. Induction by IL 1 and interferon-gamma: tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1). J. Immunol. 1986, 137:245-254.
26. Ehlers B., Dural G., Yasmum N., Lembo T., de Thoisy B., Ryser-Degiorgis M.P., Ulrich R.G., McGeoch D.J. Novel mammalian herpesviruses and lineages within the Gammaherpesvirinae: cospeciation and interspecies transfer. J. Virol. 2008, 82:3509-3516.
27. Favoreel H.W., Nauwynck H.J., Van Oostveldt P., Mettenleiter T.C., Pensaert M.B. Antibody-induced and cytoskeleton-mediated redistribution and shedding of viral glycoproteins, expressed on pseudorabies virus-infected cells. J. Virol. 1997, 71:8254-8261.
28. Foote C.E., Love D.N., Gilkerson J.R., Wellington J.E., Whalley J.M. EHV-1 and EHV-4 infection in vaccinated mares and their foals. Vet. Immunol. Immunopathol. 2006, 111:41-46.
29. Frampton A.R., Goins W.F., Cohen J.B., von Einem J., Osterrieder N., O'Callaghan D.J., Glorioso J.C. Equine herpesvirus 1 utilizes a novel herpesvirus entry receptor. J. Virol. 2005, 79:3169-3173.
30. Fries L.F., Friedman H.M., Cohen G.H., Eisenberg R.J., Hammer C.H., Frank M.M. Glycoprotein C of herpes simplex virus 1 is an inhibitor of the complement cascade. J. Immunol. 1986, 137:1636-1641.
31. Fukushi H., Tomita T., Taniguchi A., Ochiai Y., Kirisawa R., Matsumura T., Yanai T., Masegi T., Yamaguchi T., Hirai K. Gazelle herpesvirus 1: a new neurotropic herpesvirus immunologically related to equine herpesvirus 1. Virology 1997, 227:34-44.
32. Geraghty R.J., Krummenacher C., Cohen G.H., Eisenberg R.J., Spear P.G. Entry of alphaherpesviruses mediated by poliovirus receptor-related protein 1 and poliovirus receptor. Science 1998, 280:1618-1620.
33. Gilkerson J.R., Whalley J.M., Drummer H.E., Studdert M.J., Love D.N. Epidemiological studies of equine herpesvirus 1 (EHV-1) in Thoroughbred foals: a review of studies conducted in the Hunter Valley of New South Wales between 1995 and 1997. Vet. Microbiol. 1999, 68:15-25.
34. Gilkerson J.R., Whalley J.M., Drummer H.E., Studdert M.J., Love D.N. Epidemiology of EHV-1 and EHV-4 in the mare and foal populations on a Hunter Valley stud farm: are mares the source of EHV-1 for unweaned foals. Vet. Microbiol. 1999, 68:27-34.
35. Goehring L.S., Hussey G.S., Ashton L.V., Schenkel A.R., Lunn D.P. Infection of central nervous system endothelial cells by cell-associated EHV-1. Vet. Microbiol. 2010, 148:389-395.
36. Goehring L.S., Wagner B., Bigbie R., Hussey S.B., Rao S., Morley P.S., Lunn D.P. Control of EHV-1 viremia and nasal shedding by commercial vaccines. Vaccine 2010, 28:5203-5211.
37. Goodman L.B., Loregian A., Perkins G.A., Nugent J., Buckles E.L., Mercorelli B., Kydd J.H., Palu G., Smith K.C., Osterrieder N., Davis-Poynter N. A point mutation in a herpesvirus polymerase determines neuropathogenicity. PLoS Pathog. 2007, 3:e160.
38. Goodman L.B., Wagner B., Flaminio M.J.B.F., Sussman K.H., Metzger S.M., Holland R., Osterrieder N. Comparison of the efficacy of inactivated combination and modified-live virus vaccines against challenge infection with neuropathogenic equine herpesvirus type 1 (EHV-1). Vaccine 2006, 24:3636-3645.
39. Greenwood A.D., Tsangaras K., Ho S.Y., Szentiks C.A., Nikolin V.M., Ma G., Damiani A., East M.L., Lawrenz A., Hofer H., Osterrieder N. A potentially fatal mix of herpes in zoos. Curr. Biol. 2012, 22:1727-1731.
40. Griffin B.D., Verweij M.C., Wiertz E.J. Herpesviruses and immunity: the art of evasion. Vet. Microbiol. 2010, 143:89-100.
41. Gryspeerdt A.C., Vandekerckhove A.P., Garre B., Barbe F., Van de Walle G.R., Nauwynck H.J. Differences in replication kinetics and cell tropism between neurovirulent and non-neurovirulent EHV1 strains during the acute phase of infection in horses. Vet. Microbiol. 2010, 142:242-253.
42. Hannant D., O'Neill T., Ostlund E.N., Kydd J.H., Hopkin P.J., Mumford J.A. Equid herpesvirus-induced immunosuppression is associated with lymphoid cells and not soluble circulating factors. Viral Immunol. 1999, 12:313-321.
43. Hebia-Fellah I., Leaute A., Fieni F., Zientara S., Imbert-Marcille B.M., Besse B., Fortier G., Pronost S., Miszczak F., Ferry B., Thorin C., Pellerin J.L., Bruyas J.F. Evaluation of the presence of equine viral herpesvirus 1 (EHV-1) and equine viral herpesvirus 4 (EHV-4) DNA in stallion semen using polymerase chain reaction (PCR). Theriogenology 2009, 71:1381-1389.
44. Huemer H.P., Larcher C., Coe N.E. Pseudorabies virus glycoprotein III derived from virions and infected cells binds to the third component of complement. Virus Res. 1992, 23:271-280.
45. Huemer H.P., Larcher C., van Drunen Littel-van den Hurk S., Babiuk L.A. Species selective interaction of alphaherpesvirinae with the "unspecific" immune system of the host. Arch. Virol. 1993, 130:353-364.
46. Huemer H.P., Nowotny N., Crabb B.S., Meyer H., Hubert P.H. gp13 (EHV-gC): a complement receptor induced by equine herpesviruses. Virus Res. 1995, 37:113-126.
47. Hutchinson L., Browne H., Wargent V., Davis-Poynter N., Primorac S., Goldsmith K., Minson A.C., Johnson D.C. A novel herpes simplex virus glycoprotein, gL, forms a complex with glycoprotein H (gH) and affects normal folding and surface expression of gH. J. Virol. 1992, 66:2240-2250.
48. Ibrahim E.S., Kinoh M., Matsumura T., Kennedy M., Allen G.P., Yamaguchi T., Fukushi H. Genetic relatedness and pathogenicity of equine herpesvirus 1 isolated from onager, zebra and gazelle. Arch. Virol. 2007, 152:245-255.
49. Kasem S., Yu M.H., Yamada S., Kodaira A., Matsumura T., Tsujimura K., Madbouly H., Yamaguchi T., Ohya K., Fukushi H. The ORF37 (UL24) is a neuropathogenicity determinant of equine herpesvirus 1 (EHV-1) in the mouse encephalitis model. Virology 2010, 400:259-270.
50. Koppers-Lalic D., Reits E.A., Ressing M.E., Lipinska A.D., Abele R., Koch J., Marcondes Rezende M., Admiraal P., van Leeuwen D., Bienkowska-Szewczyk K., Mettenleiter T.C., Rijsewijk F.A., Tampe R., Neefjes J., Wiertz E.J. Varicelloviruses avoid T cell recognition by UL49.5-mediated inactivation of the transporter associated with antigen processing. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:5144-5149.
51. Koppers-Lalic D., Verweij M.C., Lipinska A.D., Wang Y., Quinten E., Reits E.A., Koch J., Loch S., Marcondes Rezende M., Daus F., Bienkowska-Szewczyk K., Osterrieder N., Mettenleiter T.C., Heemskerk M.H., Tampe R., Neefjes J.J., Chowdhury S.I., Ressing M.E., Rijsewijk F.A., Wiertz E.J. Varicellovirus UL 49.5 proteins differentially affect the function of the transporter associated with antigen processing TAP. PLoS Pathog. 2008, 4:e1000080.
52. Kostavasili I., Sahu A., Friedman H.M., Eisenberg R.J., Cohen G.H., Lambris J.D. Mechanism of complement inactivation by glycoprotein C of herpes simplex virus. J. Immunol. 1997, 158:1763-1771.
53. Kurtz B.M., Singletary L.B., Kelly S.D., ARF Equus caballus MHC class I is an entry receptor for equine herpesvirus type 1 (EHV-1). J. Virol. 2010, 84:9027-9034.
54. Kydd J.H., Davis-Poynter N.J., Birch J., Hannant D., Minke J., Audonnet J.C., Antczak D.F., Ellis S.A. A molecular approach to the identification of cytotoxic T-lymphocyte epitopes within equine herpesvirus 1. J. Gen. Virol. 2006, 87:2507-2515.
55. Kydd J.H., Townsend H.G.G., Hannant D. The equine immune response to equine herpesvirus-1: the virus and its vaccines. Vet. Immunol. Immunopathol. 2006, 111:15-30.
56. Kydd J.H., Wattrang E., Hannant D. Pre-infection frequencies of equine herpesvirus-1 specific, cytotoxic T lymphocytes correlate with protection against abortion following experimental infection of pregnant mares. Vet. Immunol. Immunopathol. 2003, 96:207-217.
57. Lalani A.S., Barrett J.W., McFadden G. Modulating chemokines: more lessons from viruses. Immunol. Today 2000, 21:100-106.
58. Lunn D.P., Davis-Poynter N., Flaminio M.J., Horohov D.W., Osterrieder K., Pusterla N., Townsend H.G. Equine herpesvirus-1 consensus statement. J. Vet. Intern. Med. 2009, 23:450-461.
59. Ma G., Feineis S., Osterrieder N., Van de Walle G.R. Identification and characterization of equine herpesvirus type 1 pUL56 and its role in virus-induced downregulation of major histocompatibility complex class I. J. Virol. 2012, 86:3554-3563.
60. Matsumura T., Kondo T., Sugita S., Damiani A.M., O'Callaghan D.J., Imagawa H. An equine herpesvirus Type 1 recombinant with a deletion in the gE and gI genes is avirulent in young horses. Virology 1998, 242:68-79.
61. Mercer J., Schelhaas M., Helenius A. Virus entry by endocytosis. Annu. Rev. Biochem. 2010, 79:803-833.
62. Mumford J.A., Hannant D., Jessett D.M., O'Neill T., Smith K.C., Ostlund E.N. Abortigenic and neurological disease caused by experimental infection with equid herpesvirus-1. Equine infectious diseases VII. Proceedings of the Seventh International Conference on Equine Infectious Diseases. 1994, 261-275. R&W Publications, Newmarket, United Kingdom. H. Nakajima, W. Plowright (Eds.).
63. Murphy P.M. Viral exploitation and subversion of the immune system through chemokine mimicry. Nat. Immunol. 2001, 2:116-122.
64. Neubauer A., Beer M., Brandmüller C., Kaaden O.-R., Osterrieder N. Equine herpesvirus 1 mutants devoid of glycoprotein B or M are apathogenic for mice but induce protection against challenge infection. Virology 1997, 239:36-45.
65. Nugent J., Birch-Machin, Smith K.C., Mumford J.A., Swann Z., Newton J.R., Bowden R.J., Allen G.P., Davis-Poynter N. Analysis of equid herpesvirus 1 strain variation reveals a point mutation of the DNA polymerase strongly associated with neuropathogenic versus nonneuropathogenic disease outbreaks. J. Virol. 2006, 80:4047-4060.
66. Oppenheimer-Marks N., Davis L.S., Bogue D.T., Ramberg J., Lipsky P.E. Differential utilization of ICAM-1 and VCAM-1 during the adhesion and transendothelial migration of human T lymphocytes. J. Immunol. 1991, 147:2913-2921.
67. Osterrieder N. Construction and characterization of an equine herpesvirus 1 glycoprotein C negative mutant. Virus Res. 1999, 59:165-177.
68. Osterrieder N., Van de Walle G.R. Pathogenic potential of equine alphaherpesviruses: the importance of the mononuclear cell compartment in disease outcome. Vet. Microbiol. 2010, 143:21-28.
69. Paillot R., Ellis S.A., Daly J.M., Audonnet J.C., Minke J.M., Davis-Poynter N., Hannant D., Kydd J.H. Characterisation of CTL and IFN-gamma synthesis in ponies following vaccination with a NYVAC-based construct coding for EHV-1 immediate early gene, followed by challenge infection. Vaccine 2006, 24:1490-1500.
70. Patel J.R., Heldens J. Equine herpesvirus 1 (EHV-1) and 4 (EHV-4)- epidemiology, disease and immunoprophylaxis: a brief review. Vet. J. 2005, 170:14-23.
71. Perkins G.A., Goodman L.B., Tsujimura K., Van de Walle G.R., Kim S.G., Dubovi E.J., Osterrieder N. Investigation of the prevalence of neurologic equine herpes virus type 1 (EHV-1) in a 23-year retrospective analysis (1984-2007). Vet. Microbiol. 2009, 139:375-378.
72. Pronost S., Leon A., Legrand L., Fortier C., Miszczak F., Freymuth F., Fortier G. Neuropathogenic and non-neuropathogenic variants of equine herpesvirus 1 in France. Vet. Microbiol. 2010, 145:329-333.
73. Pusterla N., David Wilson W., Madigan J.E., Ferraro G.L. Equine herpesvirus-1 myeloencephalopathy: a review of recent developments. Vet. J. 2009, 180:279-289.
74. Pusterla N., Leutenegger C.M., Wilson W.D., Watson J.L., Ferraro G.L., Madigan J.E. Equine herpesvirus-4 kinetics in peripheral blood leukocytes and nasopharyngeal secretions in foals using quantitative real-time TaqMan PCR. J. Vet. Diagn. Invest. 2005, 17:578-581.
75. Pusterla N., Mapes S., Madigan J.E., Maclachlan N.J., Ferraro G.L., Watson J.L., Spier S.J., Wilson W.D. Prevalence of EHV-1 in adult horses transported over long distances. Vet. Rec. 2009, 165:473-475.
76. Pusterla N., Mapes S., Wilson W.D. Prevalence of equine herpesvirus type 1 in trigeminal ganglia and submandibular lymph nodes of equids examined postmortem. Vet. Rec. 2010, 167:376-378.
77. Rappocciolo G., Birch J., Ellis S.A. Down-regulation of MHC class I expression by equine herpesvirus-1. J. Gen. Virol. 2003, 84:293-300.
78. Rebhun W.C., Jenkins D.H., Riis R.C., Dill S.G., Dubovi E.J., Torres A. An epizootic of blindness and encephalitis associated with a herpesvirus indistinguishable from equine herpesvirus I in a herd of alpacas and llamas. J. Am. Vet. Med. Assoc. 1988, 192:953-956.
79. Rosas C.T., Goodman L.B., Einem J.v., Osterrieder N. Equine herpesvirus type 1 modified live virus vaccines: quo vaditis?. Expert Rev. Vaccines 2006, 5:119-131.
80. Rudolph J., Seyboldt C., Granzow H., Osterrieder N. The gene 10 (UL49.5) product of equine herpesvirus 1 is necessary and sufficient for functional processing of glycoprotein M. J. Virol. 2002, 76:2952-2963.
81. Sabine M., Robertson G.R., Whalley J.M. Differentiation of sub-types of equine herpesvirus I by restriction endonuclease analysis. Aust. Vet. J. 1981, 57:148-149.
82. Said A., Azab W., Damiani A., Osterrieder N. Equine herpesvirus type 4 UL56 and UL49.5 proteins downregulate cell surface major histocompatibility complex class I expression independently of each other. J. Virol. 2012, 86:8059-8071.
83. Sasaki M., Hasebe R., Makino Y., Suzuki T., Fukushi H., Okamoto M., Matsuda K., Taniyama H., Sawa H., Kimura T. Equine major histocompatibility complex class I molecules act as entry receptors that bind to equine herpesvirus-1 glycoprotein D. Genes Cells 2011, 16:343-357.
84. Sasaki M., Kim E., Igarashi M., Ito K., Hasebe R., Fukushi H., Sawa H., Kimura T. Single amino acid residue in the A2 domain of major histocompatibility complex class I is involved in the efficiency of equine herpesvirus-1 entry. J. Biol. Chem. 2011, 286:39370-39378.
85. Shukla D., Liu J., Blaiklock P., Shworak N.W., Bai X., Esko J.D., Cohen G.H., Eisenberg R.J., Rosenberg R.D., Spear P.G. A novel role for 3-O-sulfated heparan sulfate in herpes simplex virus 1 entry. Cell 1999, 99:13-22.
86. Slater J.D., Borchers K., Thackray A.M., Field H.J. The trigeminal ganglion is a location for equine herpesvirus 1 latency and reactivation in the horse. J. Gen. Virol. 1994, 75:2007-2016.
87. Smith D., Hamblin A., Edington N. Equid herpesvirus 1 infection of endothelial cells requires activation of putative adhesion molecules: an in vitro model. Clin. Exp. Immunol. 2002, 129:281-287.
88. Smith D.J., Iqbal J., Purewal A., Hamblin A.S., Edington N. In vitro reactivation of latent equid herpesvirus-1 from CD5+/CD8+ leukocytes indirectly by IL-2 or chorionic gonadotrophin. J. Gen. Virol. 1998, 79(Pt 12):2997-3004.
89. Smith K.C., Whitwell K.E., Binns M.M., Dolby C.A., Hannant D., Mumford J.A. Abortion of virologically negative foetuses following experimental challenge of pregnant pony mares with equid herpesvirus 1. Equine Vet. J. 1992, 24:256-259.
90. Smith K.L., Allen G.P., Branscum A.J., Frank Cook R., Vickers M.L., Timoney P.J., Balasuriya U.B. The increased prevalence of neuropathogenic strains of EHV-1 in equine abortions. Vet. Microbiol. 2010, 141:5-11.
91. Soboll G., Breathnach C.C., Kydd J.H., Hussey S.B., Mealey R.M., Lunn D.P. Vaccination of ponies with the IE gene of EHV-1 in a recombinant modified live vaccinia vector protects against clinical and virological disease. Vet. Immunol. Immunopathol. 2010, 135:108-117.
92. Soboll G., Hussey S.B., Whalley J.M., Allen G.P., Koen M.T., Santucci N., Fraser D.G., Macklin M.D., Swain W.F., Lunn D.P. Antibody and cellular immune responses following DNA vaccination and EHV-1 infection of ponies. Vet. Immunol. Immunopathol. 2006, 111:81-95.
93. Soboll G., Whalley J.M., Koen M.T., Allen G.P., Fraser D.G., Macklin M.D., Swain W.F., Lunn D.P. Identification of equine herpesvirus-1 antigens recognized by cytotoxic T lymphocytes. J. Gen. Virol. 2003, 84:2625-2634.
94. Spear P.G. Herpes simplex virus: receptors and ligands for cell entry. Cell Microbiol. 2004, 6:401-410.
95. Studdert M.J., Simpson T., Roizman B. Differentiation of respiratory and abortigenic isolates of equine herpesvirus 1 by restriction endonucleases. Science 1981, 214:562-564.
96. Telford E.A., Watson M.S., Perry J., Cullinane A.A., Davison A.J. The DNA sequence of equine herpesvirus-4. J. Gen. Virol. 1998, 79(Pt 5):1197-1203.
97. Telford E.A.R., Watson M.S., McBride K., Davison A.J. The DNA sequence of equine herpesvirus-1. Virology 1992, 89:304-316.
98. Thormann N., Van de Walle G.R., Azab W., Osterrieder N. The role of secreted glycoprotein G of equine herpesvirus type 1 and type 4 (EHV-1 and EHV-4) in immune modulation and virulence. Virus Res. 2012, 169:203-211.
99. Trapp S., Einem J.v., Hofmann H., Köstler J., Wild J., Wagner R., Beer M., Osterrieder N. Potential of equine herpesvirus 1 as a vector for immunization. J. Virol. 2005, 79:5445-5454.
100. Tsujimura K., Shiose T., Yamanaka T., Nemoto M., Kondo T., Matsumura T. Equine herpesvirus type 1 mutant defective in glycoprotein E gene as candidate vaccine strain. J. Vet. Med. Sci. 2009, 71:1439-1448.
101. Van de Walle G.R., Favoreel H.W., Nauwynck H.J., Pensaert M.B. Antibody-induced internalization of viral glycoproteins and gE-gI Fc receptor activity protect pseudorabies virus-infected monocytes from efficient complement-mediated lysis. J. Gen. Virol. 2003, 84:939-948.
102. Van de Walle G.R., Goupil R., Wishon C., Damiani A., Perkins G.A., Osterrieder N. A Single-nucleotide polymorphism in a herpesvirus DNA polymerase is sufficient to cause lethal neurological disease. J. Infect. Dis. 2009, 200:20-25.
103. Van de Walle G.R., Kaufer B.B., Chbab N., Osterrieder N. Analysis of the herpesvirus chemokine-binding glycoprotein G residues essential for chemokine binding and biological activity. J. Biol. Chem. 2009, 284:5968-5976.
104. Van de Walle G.R., May M.L., Sukhumavasi W., von Einem J., Osterrieder N. Herpesvirus chemokine-binding glycoprotein G (gG) efficiently inhibits neutrophil chemotaxis in vitro and in vivo. J. Immunol. 2007, 179:4161-4169.
105. Van de Walle G.R., Peters S.T., VanderVen B.C., O'Callaghan D.J., Osterrieder N. Equine herpesvirus 1 entry via endocytosis is facilitated by alphaV integrins and an RSD motif in glycoprotein D. J. Virol. 2008, 82:11859-11868.
106. van der Meulen K., Caij B., Pensaert M., Nauwynck H. Absence of viral envelope proteins in equine herpesvirus 1-infected blood mononuclear cells during cell-associated viremia. Vet. Microbiol. 2006, 113:265-273.
107. van der Meulen K.M., Favoreel H.W., Pensaert M.B., Nauwynck H.J. Immune escape of equine herpesvirus 1 and other herpesviruses of veterinary importance. Vet. Immunol. Immunopathol. 2006, 111:31-40.
108. van der Meulen K.M., Nauwynck H.J., Pensaert M.B. Absence of viral antigens on the surface of equine herpesvirus-1-infected peripheral blood mononuclear cells: a strategy to avoid complement-mediated lysis. J. Gen. Virol. 2003, 84:93-97.
109. Vandekerckhove A.P., Glorieux S., Gryspeerdt A.C., Steukers L., Van Doorsselaere J., Osterrieder N., Van de Walle G.R., Nauwynck H.J. Equine alphaherpesviruses (EHV-1 and EHV-4) differ in their efficiency to infect mononuclear cells during early steps of infection in nasal mucosal explants. Vet. Microbiol. 2011, 152:21-28.
110. Vissani M.A., Becerra M.L., Olguin Perglione C., Tordoya M.S., Mino S., Barrandeguy M. Neuropathogenic and non-neuropathogenic genotypes of equid herpesvirus type 1 in Argentina. Vet. Microbiol. 2009, 139:361-364.
111. Wagner B., Wimer C., Freer H., Osterrieder N., Erb H.N. Infection of peripheral blood mononuclear cells with neuropathogenic equine herpesvirus type-1 strain Ab4 reveals intact interferon-alpha induction and induces suppression of anti-inflammatory interleukin-10 responses in comparison to other viral strains. Vet. Immunol. Immunopathol. 2011, 143:116-124.
112. Walter J., Balzer H.J., Seeh C., Fey K., Bleul U., Osterrieder N. Venereal shedding of equid herpesvirus-1 (EHV-1) in naturally infected stallions. J. Vet. Intern. Med. 2012, 26:1500-1504.
113. Welch H.M., Bridges C.G., Lyon A.M., Griffiths L., Edington N. Latent equid herpesviruses 1 and 4: detection and distinction using the polymerase chain reaction and cocultivation from lymphoid tissues. J. Gen. Virol. 1992, 73:261-268.
114. Whalley J.M., Ruitenberg K.M., Sullivan K., Seshadri L., Hansen K., Birch D., Gilkerson J.R., Wellington J.E. Host cell tropism of equine herpesviruses: glycoprotein D of EHV-1 enables EHV-4 to infect a non-permissive cell line. Arch. Virol. 2007, 152:717-725.
115. Whitbeck J.C., Knapp A.C., Enquist L.W., Lawrence W.C., Bello L.J. Synthesis, processing, and oligomerization of bovine herpesvirus 1 gE and gI membrane proteins. J. Virol. 1996, 70:7878-7884.
116. Wilson W.D. Equine herpesvirus 1 myeloencephalopathy. Vet. Clin. N. Am. Equine Pract. 1997, 13:53-72.
117. Wohlsein P., Lehmbecker A., Spitzbarth I., Algermissen D., Baumgartner W., Boer M., Kummrow M., Haas L., Grummer B. Fatal epizootic equine herpesvirus 1 infections in new and unnatural hosts. Vet. Microbiol. 2011, 149:456-460.